新股消息 | 石药创新递表港交所

Group 1 - The company, Shiyao Innovation Pharmaceutical Co., Ltd., has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as its sole sponsor [1] - The company focuses on the research, production, and commercialization of biopharmaceuticals, functional raw materials, and health foods [1] - According to Frost & Sullivan, the company has maintained its position as the world's largest producer of synthetic caffeine by revenue and volume from 2020 to 2024 [1][5] Group 2 - Since its establishment in 2006, the company has specialized in the research and production of high-quality caffeine, primarily used as a food additive in functional beverages [5] - As of the last feasible date (December 1, 2025), the company's products have been sold in 65 countries and regions globally, with North America and Europe being its main markets [5] - The company has established solid partnerships with leading international beverage companies, including Coca-Cola (since 2006), PepsiCo (since 2007), and Red Bull GmbH (since 2008), serving as their global caffeine supplier [5]